# Aripiprazole in Children and Adolescents With Bipolar Disorder and Attention Deficit Hyperactivity Disorder (ADHD)

> **NCT00116259** · NA · COMPLETED · sponsor: **Federal University of Rio Grande do Sul** · enrollment: 50 (estimated)

## Conditions studied

- Bipolar Disorder
- Attention Deficit Hyperactivity Disorder

## Interventions

- **DRUG:** Aripiprazole

## Key facts

- **NCT ID:** NCT00116259
- **Lead sponsor:** Federal University of Rio Grande do Sul
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-03
- **Primary completion:** 2008-01
- **Final completion:** 2008-02
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2008-08-07

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00116259

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00116259, "Aripiprazole in Children and Adolescents With Bipolar Disorder and Attention Deficit Hyperactivity Disorder (ADHD)". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00116259. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*